Discover Why Motiva Breast Implants Have Surgeons Talking!

After a thrilling decade of anticipation, the U.S. Food and Drug Administration has given the green light to Motiva Implants for breast augmentation and revision procedures. This marks a monumental milestone as it’s the first new breast implant approved in the U.S. since 2013! With a proven track record in over 70 countries, these innovative implants have undergone a remarkable six years of rigorous clinical trials. Intrigued about what makes them so special? We’ve connected with surgeons who participated in these trials and are now incorporating Motiva into their practices. Let’s dive in and discover why this breakthrough is igniting excitement in the world of breast surgery.

Meet the Experts

• Dr. Caroline Glicksman, a board-certified plastic surgeon from Wall Township, NJ
• Dr. Steven Teitelbaum, a board-certified plastic surgeon based in Santa Monica, CA
• Dr. Bradley Calobrace, a board-certified plastic surgeon located in Louisville, KY
• Dr. Tracey N. Cook, a board-eligible plastic surgeon also in Louisville, KY

What Sets Motiva Apart?

Motiva Implants are making waves for their cutting-edge features, expertly addressing persistent challenges in the realm of breast augmentation. A standout innovation is the SmoothSilk surface, hailed by surgeons for its ability to reduce inflammation and significantly lower the risk of capsular contracture—a common complication. “Based on our three-year data, we’re witnessing impressively low rates of capsular contracture,” shares Dr. Caroline Glicksman, who led the U.S. IDE study. “Capsular contracture has typically been a leading cause for implant revisions, but with Motiva, those rates are dramatically reduced!”

“Globally, Motiva implants have brought satisfaction to patients across 85 countries since their debut in 2010,” adds Dr. Tracey N. Cook from Louisville, KY. “The FDA approval comes after extensive clinical studies validating the safety and efficacy of these implants, offering both surgeons and patients exciting new options for breast augmentation.”

The Results Speak Volumes

The clinical trials paving the way for Motiva’s FDA approval involved over 1,000 patients across primary augmentation and revision groups. After three years, the capsular contracture rate for initial augmentation patients dropped below 1%, with rupture rates at a mere 0.6% and an incredible patient satisfaction rate of over 95%!

Dr. Glicksman describes the Motiva study as a “modern clinical trial,” as it didn’t just assess the implants alone. It gathered comprehensive data on incision size, implant placement, and surgical techniques to ensure a holistic approach. “We didn’t just evaluate the device; we analyzed how contemporary surgical practices influence outcomes,” she elaborates. “This comprehensive approach is what sets this trial apart.”

Positioning: Above or Behind the Muscle?

Most surgeons involved in the study chose to place implants behind the muscle, with over 95% favoring a dual-plane technique to minimize rippling and capsular contracture. While sub-fascial placement (above the muscle) is gaining traction for its quicker recovery benefits, Dr. Glicksman cautions, “We still need more data to fully back those claims. Continuous data collection will be essential as these methods evolve.”

The ‘Softness’ Sensation

One feature that surgeons rave about is the remarkable softness of the implants. “The feel of these implants mimics natural breast tissue so closely, it becomes nearly indistinguishable,” notes Dr. Teitelbaum. “Patients who have been apprehensive about implants feeling firm or unnatural are particularly eager about this new option.”

Dr. Glicksman reports that her patients often comment on the unparalleled softness. “Many say these are the most natural-feeling implants they’ve ever touched. They compare it to memory foam, and they adore how comfortable and lifelike they are. This is a leading reason many choose Motiva,” she reveals.

Motiva offers two unique styles: the SmoothSilk Round implant, perfect for achieving upper pole fullness, and the Ergonomix, which adapts to body positioning for a subtle teardrop aesthetic. “These options empower surgeons to customize the implant selection based on individual patient desires and anatomical factors,” explains Dr. Calobrace.

Is Motiva Right for You?

Currently, Motiva Implants are FDA-approved for both primary augmentation and revision cases. While they aren’t yet cleared for reconstruction, surgeons agree they are particularly well-tailored for first-time augmentation patients or those looking to update older implants.

“These implants are ideal for individuals with sufficient soft tissue seeking a natural look and feel,” advises Dr. Glicksman. “They make fantastic revision implants due to their softness and comfort. Many of my revision patients are astounded by how much better these feel compared to their former implants,” she adds.

What Lies Ahead?

“This is an exhilarating moment for both surgeons and patients alike,” Dr. Glicksman asserts. “It’s been over ten years since we’ve welcomed a new option like this, and it’s clear that innovation thrives when robust data and collaborative efforts unite.”